Showing results (1621-1630 of 4,515) with videos related to
Sort By:
Pageof 452
Advances in Therapy|August 25, 2011
Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at The Radisson Edwardian Heathrow Hotel, Hayes, Middlesex, UKStephen C L Gough, Cristóbal Belda-Iniesta, Christopher Poole, et al.Advances in Therapy|September 17, 2011
Update on adjuvant hormonal treatment of early breast cancerJ Lao Romera, T J Puertolas Hernández, I Peláez Fernández, et al.Advances in Therapy|August 12, 2011
Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an updateTareq Abu-Salah, Rajiv DhandAdvances in Therapy|July 28, 2011
The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophenChristoph Kapitza, Milan Zdravkovic, Charlotte Hindsberger, et al.Advances in Therapy|October 4, 2011
Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumorsWilliam H Ludlam, Lowell AnthonyAdvances in Therapy|October 12, 2011
The "MESACA" study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosisAngela Notarnicola, Silvio Tafuri, Lucrezia Fusaro, et al.Advances in Therapy|August 23, 2011
Tafluprost: a novel prostaglandin analog for treatment of glaucomaMina B Pantcheva, Leonard K Seibold, Nida S Awadallah, et al.Advances in Therapy|August 3, 2011
What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?Alejandro de la Sierra, Jorge SalazarAdvances in Therapy|January 25, 2012
Amlodipine/valsartan single-pill combination: a prospective, observational evaluation of the real-life safety and effectiveness in the routine treatment of hypertensionYuri Karpov, Neelesh Dongre, Alexey Vigdorchik, et al.Advances in Therapy|January 25, 2012
Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxinSreeneeranj Kasichayanula, Ming Chang, Xiaoni Liu, et al.Pageof 452